论文部分内容阅读
Objective: Colorectal cancer (CRC) is one of the most common malignant tumors.Most of advanced CRC will progress after first-line treatment;therefore, seeking an efficient and low toxic maintaining regimen to prolong progression free survival (PFS) becomes a hot topic.